Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer

• Juraj Hlavaty,

  Affiliations Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria, Christian-Doppler Laboratory for Innovative Immunotherapy, Vienna, Austria

  ⨯
• Helga Petznek,

  Affiliation Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria

  ⨯
• Harry Holzmüller,

  Affiliation Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria

  ⨯
• Angelika Url,

  Affiliation Institute of Pathology and Forensic Veterinary Medicine, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria

  ⨯
• Gerrit Jandl,

  Affiliation Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria

  ⨯
• André Berger,

  Affiliation Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany

  ⨯
• Brian Salmons,

  Affiliation Austrianova Singapore Pte Ltd., Singapore, Singapore

  ⨯
• Walter H. Günzburg,

  Affiliations Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria, Austrianova Singapore Pte Ltd., Singapore, Singapore

  ⨯
• Matthias Renner

  * E-mail: Matthias.Renner@pei.de

  Affiliations Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria, Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany

  ⨯